Volume 7 Issue 6
Nov.  2016
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2016  >  7(6): 444-448
Cai Zhenxing, Chen Xiaobo, Yan Lyunan, et al. Analysis of risk factors of initial poor graft function after living donor liver transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(6): 444-448. doi: 10.3969/j.issn.1674-7445.2016.06.006
Citation: Cai Zhenxing, Chen Xiaobo, Yan Lyunan, et al. Analysis of risk factors of initial poor graft function after living donor liver transplantation[J]. ORGAN TRANSPLANTATION, 2016, 7(6): 444-448. doi: 10.3969/j.issn.1674-7445.2016.06.006
shu

Analysis of risk factors of initial poor graft function after living donor liver transplantation

doi: 10.3969/j.issn.1674-7445.2016.06.006

  • Department of Liver Surgery, Liver Transplantation Center, West China Hospital of Sichuan University, Chengdu 610041, China

More Information
  • Corresponding author: Xu Mingqing. E-mail:xumingqing0018@163.com.
  • Received Date: 2016-08-02
    Available Online: 2021-03-19
  • Publish Date: 2016-11-15
    Abstract
  •   Objective   To identify the risk factors of the incidence rate of initial poor graft function (IPGF) in recipients after living donor liver transplantation.   Methods   Clinical data of 309 patients undergoing living donor liver transplantation were retrospectively analyzed. Candidate risk factors: (1) donor factors included age, gender and body mass index (BMI); (2) recipient factors included age, gender, BMI and preoperative Child-Pugh classification, model for end-stage liver disease (MELD) grading, preoperative renal insufficiency, serum total bilirubin elevation, hyponatremia and hypopotassaemia; (3) graft factors included graft cold ischemia time, graft recipient weight ratio (GRWR); (4) recipient surgery factors included total operation time, blood loss volume, blood transfusion volume, platelet transfusion and anhepatic phase≥100 min. Single factor analysis was performed to identify the potential risk factors of IPGF. Logistic regression analysis was conducted to explore independent risk factors.   Results   and   Conclusions   Child-Pugh C of preoperative recipient liver function, MELD score≥20, serum total bilirubin elevation(>68.4 μmol/L), hyponatremia(＜135 mmol/L), hypopotassaemia (＜3.5 mmol/L) and anhepatic phase≥100 min were potential risk factors of IPGF (all P＜0.05). Child-Pugh C of preoperative recipient liver function was an independent risk factor of the incidence rate of IPGF following living donor liver transplantation (P=0.019).

     

    • FullText(HTML)
  • loading
    • References(22)
  • [1]
    Salvalaggio P, Afonso RC, Felga G, et al. A proposal to grade the severity of early allograft dysfunction after liver transplantation[J]. Einstein, 2013, 11 (1): 23-31. doi: 10.1590/S1679-45082013000100006
    [2]
    Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors[J]. Liver Transpl, 2010, 16 (8): 943-949. doi: 10.1002/(ISSN)1527-6473
    [3]
    Akamatsu N, Sugawara Y. Living-donor liver transplantation and hepatitis C[J]. HPB Surg, 2013: 985972. http://cn.bing.com/academic/profile?id=2084487664&encoded=0&v=paper_preview&mkt=zh-cn
    [4]
    Azevedo LD, Stucchi RS, Ataíde EC, et al. Assessment of causes of early death after twenty years of liver transplantation[J]. Transplant Proc, 2013, 45 (3): 1116-1118. doi: 10.1016/j.transproceed.2013.02.015
    [5]
    Croome KP, Hernandez-Alejandro R, Chandok N. Early allograft dysfunction is associated with excess resource utilization after liver transplantation[J]. Transplant Proc, 2013, 45 (1): 259-264. doi: 10.1016/j.transproceed.2012.07.147
    [6]
    Sirivatanauksorn Y, Taweerutchana V, Limsrichamrern S, et al. Analysis of donor risk factors associated with graft outcomes in orthotopic liver transplantation[J]. Transplant Proc, 2012, 44 (2): 320-323. doi: 10.1016/j.transproceed.2011.12.031
    [7]
    Chen H, Peng CH, Shen BY, et al. Multi-factor analysis of initial poor graft function after orthotopic liver transplantation[J]. Hepatobiliary Pancreat Dis Int, 2007, 6 (2): 141-146. http://cn.bing.com/academic/profile?id=156034704&encoded=0&v=paper_preview&mkt=zh-cn
    [8]
    Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation-a multivariate analysis[J]. Transplantation, 1993, 55 (4): 807-813. doi: 10.1097/00007890-199304000-00024
    [9]
    Pomposelli JJ, Goodrich NP, Emond JC, et al. Patterns of early allograft dysfunction in adult live donor liver transplantation: the A2ALL experience[J]. Transplantation, 2016, 100 (7): 1490-1499. doi: 10.1097/TP.0000000000001240
    [10]
    Hong SH, Kwak JA, Chon JY, et al. Prediction of early allograft dysfunction using serum phosphorus level in living donor liver transplantation[J]. Transplant Int, 2013, 26 (4): 402-410. doi: 10.1111/tri.12058
    [11]
    Wadei HM, Lee DD, Croome KP, et al. Early allograft dysfunction after liver transplantation is associated with short- and long-term kidney function impairment[J]. Am J Transplant, 2016, 16 (3): 850-859. doi: 10.1111/ajt.13527
    [12]
    Lee DD, Singh A, Burns JM, et al. Early allograft dysfunction in liver transplantation with donation after cardiac death donors results in inferior survival[J]. Liver Transpl, 2014, 20 (12): 1447-1453. http://cn.bing.com/academic/profile?id=2002754214&encoded=0&v=paper_preview&mkt=zh-cn
    [13]
    Ikegami T, Imai D, Wang H, et al. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation[J]. Transplantation, 2014, 97 (4): 457-462. http://cn.bing.com/academic/profile?id=2039286356&encoded=0&v=paper_preview&mkt=zh-cn
    [14]
    Hoyer DP, Paul A, Gallinat A, et al. Donor information based prediction of early allograft dysfunction and outcome in liver transplantation[J]. Liver Int, 2015, 35 (1): 156-163. doi: 10.1111/liv.12443
    [15]
    Cameron AM, Ghobrial RM, Yersiz H, et al. Optimal utilization of donor grafts with extended criteria: a single-center experience in over 1 000 liver transplants[J]. Ann Surg, 2006, 243 (6): 748-753. doi: 10.1097/01.sla.0000219669.84192.b3
    [16]
    Johnson SR, Alexopoulos S, Curry M, et al. Primary nonfunction (PNF) in the MELD era: an SRTR database analysis[J]. Am J Transplant, 2007, 7 (4): 1003-1009. doi: 10.1111/ajt.2007.7.issue-4
    [17]
    Bruns H, Lozanovski VJ, Schultze D, et al. Prediction of postoperative mortality in liver transplantation in the era of MELD-based liver allocation: a multivariate analysis[J]. PLoS One, 2014, 9 (6): e98782. doi: 10.1371/journal.pone.0098782
    [18]
    Khandoga A, Iskandarov E, Angele M, et al. Model for end-stage liver disease score in the first 3 weeks after liver transplantation as a predictor for long-term outcome[J]. Eur J Gastroenterol Hepatol, 2016, 28 (2): 153-158. http://cn.bing.com/academic/profile?id=2112535440&encoded=0&v=paper_preview&mkt=zh-cn
    [19]
    Taki-Eldin A, Zhou L, Xie HY, et al. Triiodothyronine attenuates hepatic ischemia/reperfusion injury in a partial hepatectomy model through inhibition of proinflammatory cytokines, transcription factors, and adhesion molecules[J]. J Surg Res, 2012, 178 (2): 646-656. doi: 10.1016/j.jss.2012.05.069
    [20]
    Beck-Schimmer B, Bonvioi JM, Schadde E, et al. Conditioning with sevoflurane in liver transplantation: results of a multicenter randomized controlled trial[J]. Transplantation, 2015, 99 (8): 1606-1612. doi: 10.1097/TP.0000000000000644
    [21]
    Sibulesky L, Li M, Hansen RN, et al. Impact of cold ischemia time on outcomes of liver transplantation: a single center experience[J]. Ann Transplant, 2016, 21: 145-151. doi: 10.12659/AOT.896190
    [22]
    Ijtsma AJ, van der Hilst CS, de Boer MT, et al. The clinical relevance of the anhepatic phase during liver transplantation[J]. Liver Transpl, 2009, 15 (9): 1050-1055. doi: 10.1002/lt.v15:9
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (170) PDF downloads(13) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return